Fauci returns to Weill Cornell Medicine for documentary screening

The documentary, which will debut nationwide on PBS March 21, illustrates the full scope of his career set against the backdrop of his final years of service presiding over the nation’s response to the COVID-19 pandemic.

Celebrating Match Day success at Weill Cornell Medicine

Graduating medical students in the Weill Cornell Medical College Class of 2023 learned on national Match Day where they will be doing their internship and residency training – setting the stage for the next several years of their medical careers and lives.

Children’s pandemic mental health linked to family finances

Financial disruption as a result of pandemic containment policies in the United States adversely influenced children’s mental health, according to a new study co-led by Weill Cornell Medicine and Columbia University investigators. 

Study identifies human genes enabling SARS-CoV-2 infection

The activity of a gene called CIART is a key factor in the establishment of the viral infection that causes COVID-19, according to a study from researchers at Weill Cornell Medicine and New York University Grossman School of Medicine.

“Be Bold, Be You” is focus of Women+ in Health Care Leadership Symposium

Victoria Bent MHA '23 is one of the organizers of the Women+ in Health Care Leadership Symposium. The event is sponsored by the Sloan Program in Health Administration in the Cornell Jeb E. Brooks School of Public Policy and it will focus on personal development skills.

Around Cornell

3D-printed scaffold could improve breast reconstruction results

Weill Cornell Medicine investigators have developed a technique to help surgeons reconstruct more natural-looking nipples for patients who have undergone breast reconstruction after mastectomy to treat breast cancer.

Women face higher risk after coronary artery bypass surgery

Compared with men, women continue to have a roughly 30-40% higher risk of dying following coronary artery bypass surgery, according to a large study led by investigators at Weill Cornell Medicine and NewYork-Presbyterian/Weill Cornell Medical Center.

Differences in animal biology can affect cancer drug development

A small but significant metabolic difference between human and mouse lung tumor cells has been discovered by Weill Cornell Medicine researchers, explaining a discrepancy in previous study results and pointing toward new strategies for developing cancer treatments.

Weill Cornell Medicine awarded grant for lymphoma research

Weill Cornell Medicine has been awarded a five-year, $4.2 million grant by the National Cancer Institute to investigate the molecular mechanisms by which immune cells interact with Epstein-Barr virus to cause lymphoma, particularly in people living with HIV.